North Korea has been developing its missile program for decades, and a test last month let the world know that it has the U.S. East Coast within range of its latest Hwasong model.
North Korea is reportedly testing using anthrax on its missiles.
It looks like the CME will win the battle of Bitcoin futures
They were triggered in the initial hours of their trading as the January contract rose as much as 26 percent. On its debut on Dec 10, the Cboe traded almost 4,000 contracts during the full session.
The report, based off of a source in South Korea, said that it did not have confirmation about whether the tests had been successful. "North Korea is also pursuing chemical and biological weapons which could also be delivered by missile".
Rebecca Hersman, a former Defense Department deputy assistant secretary for countering weapons of mass destruction, was quoted in a Washington Post article speaking about the country's bio-weapon program: "North Korea is bad enough when you're talking about their nuclear and missiles program".
The article notably said President Donald Trump is "running wild", "insane" and "bluffing" when condemning inter-continental ballistic missile (ICBM) tests. As if on cue, a report now indicates that Kim Jong-un is intent upon strapping such agents, including anthrax spores and smallpox, onto long-range missiles, and his regime is currently testing whether these bio weapons can survive an intercontinental voyage intact.